{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:42:27Z","timestamp":1790685747706,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,18]],"date-time":"2022-12-18T00:00:00Z","timestamp":1671321600000},"content-version":"am","delay-in-days":320,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010877","name":"ViiV Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004571","name":"Minist\u00e8re des Affaires Sociales et de la Sant\u00e9","doi-asserted-by":"publisher","award":["AOM06022"],"award-info":[{"award-number":["AOM06022"]}],"id":[{"id":"10.13039\/501100004571","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007054","name":"Meso Scale Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.jad.2021.12.012","type":"journal-article","created":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T18:34:35Z","timestamp":1639247675000},"page":"335-343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The GG genotype of the serotonin 4 receptor genetic polymorphism, rs1345697, is associated with lower remission rates after antidepressant treatment: Findings from the METADAP cohort"],"prefix":"10.1016","volume":"299","author":[{"given":"Vianney","family":"Poinsignon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Colle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalil El","family":"Asmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indira","family":"Mendez-David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis J","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abd El Kader","family":"Ait Tayeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Chappell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Gressier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Herrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"F\u00e8ve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Becquemont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Corruble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Verstuyft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2021.12.012_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107712","article-title":"Role of serotonin 4 receptor in the growth of hippocampal neurons during the embryonic development in mice","volume":"158","author":"Agrawal","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jad.2021.12.012_bib0002","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.neuropharm.2016.08.037","article-title":"The absence of 5-HT4 receptors modulates depression- and anxiety-like responses and influences the response of fluoxetine in olfactory bulbectomised mice: adaptive changes in hippocampal neuroplasticity markers and 5-HT1A autoreceptor","volume":"111","author":"Amig\u00f3","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jad.2021.12.012_bib0003","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.physbeh.2014.02.035","article-title":"Anhedonia was associated with the dysregulation of hippocampal HTR4 and microRNA Let-7a in rats","volume":"129","author":"Bai","year":"2014","journal-title":"Physiol. Behav."},{"issue":"1615","key":"10.1016\/j.jad.2021.12.012_bib0004","article-title":"Serotonin and beyond: therapeutics for major depression","volume":"368","author":"Blier","year":"2013","journal-title":"Philosoph. Transac. Royal Soc. B."},{"issue":"6","key":"10.1016\/j.jad.2021.12.012_bib0005","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.neuropharm.2008.05.013","article-title":"5-HT(4) receptors: history, molecular pharmacology and brain functions","volume":"55","author":"Bockaert","year":"2008","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.jad.2021.12.012_bib0006","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/gim.2016.87","article-title":"Standardizing terms for clinical pharmacogenetic test results: consensus terms from the clinical pharmacogenetics implementation consortium (CPIC)","volume":"19","author":"Caudle","year":"2017","journal-title":"Gene. Med."},{"issue":"3","key":"10.1016\/j.jad.2021.12.012_bib0007","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/s41386-019-0540-3","article-title":"Prophylactic efficacy of 5-HT4R agonists against stress","volume":"45","author":"Chen","year":"2020","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.jad.2021.12.012_bib0008","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1523\/JNEUROSCI.2806-03.2004","article-title":"Attenuated response to stress and novelty and hypersensitivity to seizures in 5-HT4 receptor knock-out mice","volume":"24","author":"Compan","year":"2004","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.jad.2021.12.012_bib0009","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1051\/jbio\/2004198010037","article-title":"[Feeding disorders in 5-HT4 receptor knockout mice]","volume":"198","author":"Compan","year":"2004","journal-title":"J. Soc. Biol."},{"issue":"3","key":"10.1016\/j.jad.2021.12.012_bib0010","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/wps.20260","article-title":"Treating major depressive episodes with antidepressants can induce or worsen metabolic syndrome: results of the METADAP cohort","volume":"14","author":"Corruble","year":"2015","journal-title":"World psych."},{"issue":"4","key":"10.1016\/j.jad.2021.12.012_bib0011","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.clpt.2006.01.007","article-title":"Environmental and genetic factors associated with morphine response in the postoperative period","volume":"79","author":"Coulbault","year":"2006","journal-title":"Clin. Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.jad.2021.12.012_bib0012","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.biopsych.2019.08.009","article-title":"Rapid anxiolytic effects of RS67333, a serotonin type 4 receptor agonist, and diazepam, a benzodiazepine, are mediated by projections from the prefrontal cortex to the dorsal raphe nucleus","volume":"87","author":"Faye","year":"2020","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2021.12.012_bib0013","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000508680","article-title":"Activation and blockade of serotonin-4 receptors in the lateral habenula produce antidepressant effects in the hemiparkinsonian rat","volume":"80","author":"Guo","year":"2020","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.jad.2021.12.012_bib0014","unstructured":"Guy W. (1976). ECDEU Assessment Manual for Psychopharmacology. 338. US Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs."},{"issue":"11","key":"10.1016\/j.jad.2021.12.012_bib0015","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1002\/hbm.22123","article-title":"The 5-HT4 receptor levels in hippocampus correlates inversely with memory test performance in humans","volume":"34","author":"Haahr","year":"2013","journal-title":"Hum Brain Mapp"},{"key":"10.1016\/j.jad.2021.12.012_bib0016","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psych."},{"issue":"2","key":"10.1016\/j.jad.2021.12.012_bib0017","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/cpt.147","article-title":"Clinical pharmacogenetics implementation consortium (CPIC) guideline for CYP2D6 and CYP2C19 genotypes and dosing of selective serotonin reuptake inhibitors","volume":"98","author":"Hicks","year":"2015","journal-title":"Clin. Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.jad.2021.12.012_bib0018","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1186\/1479-7364-4-6-402","article-title":"Intronic polymorphisms of cytochromes P450","volume":"4","author":"Ingelman-Sundberg","year":"2010","journal-title":"Hum. Genomics"},{"issue":"1","key":"10.1016\/j.jad.2021.12.012_bib0019","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/s12888-019-2222-4","article-title":"The humanistic and economic burden of treatment-resistant depression in Europe: a cross-sectional study","volume":"19","author":"Jaffe","year":"2019","journal-title":"BMC Psychiatry"},{"issue":"7809","key":"10.1016\/j.jad.2021.12.012_bib0021","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.jad.2021.12.012_bib0022","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.2174\/138945009789735200","article-title":"Serotonin receptors, type 4: a new hope?","volume":"10","author":"Lucas","year":"2009","journal-title":"Curr Drug Targets"},{"issue":"5","key":"10.1016\/j.jad.2021.12.012_bib0023","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.neuron.2007.07.041","article-title":"Serotonin4 (5-HT4) receptor agonists are putative antidepressants with a rapid onset of action","volume":"55","author":"Lucas","year":"2007","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.jad.2021.12.012_bib0024","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyu034","article-title":"Familial risk for major depression is associated with lower striatal 5-HT\u2084 receptor binding","volume":"18","author":"Madsen","year":"2014","journal-title":"Intern. J. Neuropsychopharmac."},{"issue":"6","key":"10.1016\/j.jad.2021.12.012_bib0025","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/npp.2013.332","article-title":"Rapid anxiolytic effects of a 5-HT4 receptor agonist are mediated by a neurogenesis-independent mechanism","volume":"39","author":"Mendez-David","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2021.12.012_bib0026","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3389\/fphar.2021.650750","article-title":"CYP2D6 Reduced function variants and genotype\/phenotype translations of CYP2D6 intermediate metabolizers: implications for personalized drug dosing in psychiatry","volume":"12","author":"Molden","year":"2021","journal-title":"Front Pharmacol."},{"key":"10.1016\/j.jad.2021.12.012_bib0027","first-page":"1","article-title":"A role for 5-HT4 receptors in human learning and memory","author":"Murphy","year":"2019","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2021.12.012_bib0028","first-page":"1","article-title":"Translating the promise of 5HT4 receptor agonists for the treatment of depression","author":"Murphy","year":"2020","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2021.12.012_bib0029","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.614048","article-title":"Selective serotonin reuptake inhibitor pharmaco-omics: mechanisms and prediction","volume":"11","author":"Nguyen","year":"2021","journal-title":"Front Pharmacol."},{"issue":"9","key":"10.1016\/j.jad.2021.12.012_bib0030","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/sj.mp.4001133","article-title":"Association between serotonin 4 receptor gene polymorphisms and bipolar disorder in Japanese case-control samples and the NIMH genetics initiative bipolar pedigrees","volume":"7","author":"Ohtsuki","year":"2002","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2021.12.012_bib0031","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1741-7015-11-132","article-title":"Personalized medicine in psychiatry: problems and promises","volume":"11","author":"Ozomaro","year":"2013","journal-title":"BMC Med."},{"issue":"1","key":"10.1016\/j.jad.2021.12.012_bib0032","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/dneu.20306","article-title":"Serotonin decreases generation of dopaminergic neurons from mesencephalic precursors via serotonin type 7 and type 4 receptors","volume":"67","author":"Parga","year":"2007","journal-title":"Dev. Neurobiol."},{"issue":"5","key":"10.1016\/j.jad.2021.12.012_bib0033","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1017\/S1461145711000782","article-title":"Modulation of neuroplasticity pathways and antidepressant-like behavioural responses following the short-term (3 and 7 days) administration of the 5-HT4 receptor agonist RS67333","volume":"15","author":"Pascual-Brazo","year":"2012","journal-title":"Internat. J. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.jad.2021.12.012_bib0034","first-page":"301","article-title":"Pharmacog\u00e9n\u00e9tique des m\u00e9dicaments antid\u00e9presseurs\u00a0: \u00e9tat des connaissances et des pratiques \u2013 recommandations du R\u00e9seau national de pharmacog\u00e9n\u00e9tique (RNPGx)","volume":"72","author":"Quaranta","year":"2017","journal-title":"Th\u00e9rapie"},{"issue":"4","key":"10.1016\/j.jad.2021.12.012_bib0035","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000077365","article-title":"Altered 5-HT2A and 5-HT4 postsynaptic receptors and their intracellular signalling systems IP3 and cAMP in brains from depressed violent suicide victims","volume":"49","author":"Rosel","year":"2004","journal-title":"Neuropsychobiology"},{"issue":"4","key":"10.1016\/j.jad.2021.12.012_bib0036","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1177\/107385840000600408","article-title":"The multiplicity of serotonin receptors: uselessly diverse molecules or an embarrassment of riches?","volume":"6","author":"Roth","year":"2000","journal-title":"The Neuroscientist"},{"issue":"11","key":"10.1016\/j.jad.2021.12.012_bib0037","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"9","key":"10.1016\/j.jad.2021.12.012_bib0038","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1038\/sj.npp.1301131","article-title":"Report by the ACNP task force on response and remission in major depressive disorder","volume":"31","author":"Rush","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.jad.2021.12.012_bib0039","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/1073858414561303","article-title":"Serotonin 1A and serotonin 4 receptors: essential mediators of the neurogenic and behavioral actions of antidepressants","volume":"22","author":"Samuels","year":"2016","journal-title":"Neuroscientist"},{"issue":"1","key":"10.1016\/j.jad.2021.12.012_bib0040","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.clpt.2005.10.002","article-title":"A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants","volume":"79","author":"Sim","year":"2006","journal-title":"Clin. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.jad.2021.12.012_bib0041","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/bcpt.12827","article-title":"The catechol-o-methyltransferase Val(108\/158)met genetic polymorphism cannot be recommended as a biomarker for the prediction of venlafaxine efficacy in patients treated in psychiatric settings","volume":"121","author":"Taranu","year":"2017","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"1","key":"10.1016\/j.jad.2021.12.012_bib0043","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.jad.2021.12.012_bib0044","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1176\/appi.ajp.2009.09070932","article-title":"Genome-wide pharmacogenetics of antidepressant response in the GENDEP project","volume":"167","author":"Uher","year":"2010","journal-title":"Am. J. Psychiatry"},{"issue":"23","key":"10.1016\/j.jad.2021.12.012_bib0045","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.2174\/13816128113196660734","article-title":"Serotonin 5-HT4 receptors: a new strategy for developing fast act...: ingenta connect","volume":"20","author":"Vidal","year":"2014","journal-title":"Curr. Pharmaceut. Design"},{"issue":"1","key":"10.1016\/j.jad.2021.12.012_bib0046","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1176\/appi.ajp.163.1.148","article-title":"How should remission from depression be defined? The depressed patient's perspective","volume":"163","author":"Zimmerman","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.jad.2021.12.012_bib0047","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jad.2013.04.028","article-title":"Severity classification on the Hamilton Depression Rating Scale","volume":"150","author":"Zimmerman","year":"2013","journal-title":"J. Affect Disord."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032721013306?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032721013306?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T02:30:08Z","timestamp":1759026608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032721013306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":45,"alternative-id":["S0165032721013306"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2021.12.012","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The GG genotype of the serotonin 4 receptor genetic polymorphism, rs1345697, is associated with lower remission rates after antidepressant treatment: Findings from the METADAP cohort","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2021.12.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}